40 LONGEVITY
looks only at the ocular region in photographs. It is trained to predict chronological age from cropped patches of the area around the eyes, where lines, wrinkles, pigmentation changes and micro-texture provide a strong ageing signal. ‘Eye age’ is based on the ‘PhotoAgeClock’ research, in which a deep model was trained on thousands of high-resolution images People with a high screen time lifestyle (8+
hours/day) show a significantly higher eye age. These people treated their skin with placebo or verum (containing 3% SkinCharge CLR) for three months. Skin treatment with 3% SC Complex led to a significant reduction of eye age and compensates largely for the extensive exposure to screens (Figure 9). Based on data obtained with 30 volunteers. ** p < 0.01
Screen time and digital ageing The high amount of daily screen time leaves its mark on our faces. Facial expressions, tension and stiffness can affect the formation of wrinkles all over the face. This is particularly true when facial expressions are continuously influenced. Three percent SC Complex has a strong anti-
ageing effect for digital resilience by reducing fine lines on the cheeks, reducing crow’s feet wrinkles and eye bags whilst enhancing skin’s elasticity and firmness.
Method The use of different methods of measurement is essential for providing a 360°-view on the effectiveness of an active ingredient. Therefore, in the presented studies, different technologies as well as human assessments were performed. Cheeks’ fine lines were determined with Haut.
AI. Crow’s feet wrinkles were determined with AEVA-HE, eyebags and skin elasticity with clinical expert evaluation, and skin firmness by self- evaluation. Parameters were determined on skin of volunteers with increased screen time.
Results
The measurable improvement in skin texture, wrinkling, elasticity and firmness is clearly evident in all age groups among the test subjects (Figures 10 and 11). This makes SC Complex a fundamental basis for supporting the skin in every phase of life, as nowadays increased exposure to screens often occurs regardless of age.
Consumer study including screen time behaviour tracking and skin feeling A placebo-controlled 14-day user study was conducted with people who spend a lot of time in front of screens (Figure 12). Volunteers using SC Complex benefited from an uplifted skin feeling despite spending the same amount of time in front of screens (Figure 13). With this new approach of behaviour tracking
a link can be made to cosmetic properties and the kind of consumer that benefits from using and integrating this active in his or her personal lifestyle.
Conclusion Modern lifestyles include an excessive amount
PERSONAL CARE MAGAZINE May 2026
AGE 50+
Placebo ■ SC Complex (3%) ■
50 40 30 20 10 0
-10 -20 -30
* * *
Cheeks Fine Lines
Crows Feet Wrinkles
Eye Bags Elasticity Skin Firmness Skin
Figure 10: The treatment with SC Complex improves a large number of ageing-associated skin parameters for people with high screen time
Before
AGE 30+
After* * *
AGE 40+
Figure 11: The treatment with SC Complex provides anti-ageing benefits for high screen time users of all ages
of screen time. In fact, the number of hours the average person spends behind a digital screen is higher than the combined hours we eat and sleep. The implications of this behaviour are abundant. Digital eye strain where the eye area can
dry out and become inflamed is a common phenomenon. Other consequences of high screen time include the reduced quality of sleep. It is not surprising that high screen time users show an
accelerated skin ageing phenotype, of which the modern consumer is increasingly aware. SC Complex was developed to provide
important support for the facial skin of the high screen time user. In numerous in vitro, ex vivo, and in vivo studies, it could be shown that SC Complex enables the skin to compensate for the accelerated ageing processes taking place in the skin of people who spend a large number of hours behind a digital screen every day. PCM
www.personalcaremagazine.com
Change in (%)
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
